Product Name

  • Name

    MONOCROTALINE

  • EINECS 628-506-2
  • CAS No. 315-22-0
  • Article Data5
  • CAS DataBase
  • Density 1.35 g/cm3
  • Solubility 11.86g/L(temperature not stated)
  • Melting Point 204 °C
  • Formula C16H23NO6
  • Boiling Point 537.3 °C at 760 mmHg
  • Molecular Weight 325.362
  • Flash Point 278.7 °C
  • Transport Information UN 1544 6.1/PG 3
  • Appearance white to light tan powder
  • Safety 36/37/39-45
  • Risk Codes 25-40
  • Molecular Structure Molecular Structure of 315-22-0 (MONOCROTALINE)
  • Hazard Symbols ToxicT
  • Synonyms 20-Norcrotalanan-11,15-dione,14,19-dihydro-12,13-dihydroxy-, (13a,14a)-;Monocrotaline (6CI,7CI,8CI);(-)-Monocrotaline;2H-[1,6]Dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione,4,5,8,10,12,13,13a,13b-octahydro-4,5-dihydroxy-3,4,5-trimethyl-,[3R-(3R*,4R*,5R*,13aR*,13bR*)]-;Monocrotalin;NSC 28693;Monocrotaline;(13-alpha,14-alpha)-14,19-Dihydro-12,13-dihydroxy-20-norcrotalanan-11,15-dione;Crotaline;
  • PSA 96.30000
  • LogP -0.45470

Synthetic route

monocrotaline methylene acetal
110121-56-7, 121719-98-0, 121720-00-1

monocrotaline methylene acetal

monocrotaline
315-22-0

monocrotaline

Conditions
ConditionsYield
With trityl tetrafluoroborate In dichloromethane for 48h; Heating;86%
With hydrogenchloride; trityl tetrafluoroborate 1.) CH2Cl2, reflux, 48 h, 2.) room temperature, 17.5 h; Yield given. Multistep reaction;
Conditions
ConditionsYield
With hydrogenchloride In ethylene glycol at 110℃; for 2h;75%
Monocrotaline N-oxide
35337-98-5

Monocrotaline N-oxide

monocrotaline
315-22-0

monocrotaline

Conditions
ConditionsYield
With intestinal gut bacteria in a human fecal suspension at 37℃; for 5h; Enzymatic reaction;38%
grahamine
24583-56-0

grahamine

monocrotaline
315-22-0

monocrotaline

Conditions
ConditionsYield
With hydrogenchloride
(2R,3R,4R)-2,3,4-trimethyl-2,3-methylenedioxypentanedioic anhydride
109391-24-4, 121787-06-2

(2R,3R,4R)-2,3,4-trimethyl-2,3-methylenedioxypentanedioic anhydride

monocrotaline
315-22-0

monocrotaline

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 1) Bu2SnO / 1) benzene, reflux, 24 h, 2) toluene, a) -40 deg C, 2 h, b) to r.t.
2: 1) Et3N, 2,4,6-trichlorobenzoyl chloride, 2) 4-(dimethylamino)pyridine / 1) THF, r.t., 3.5 h, 2) THF, toluene, reflux, 10 min
3: 86 percent / Ph3C*BF4 / CH2Cl2 / 48 h / Heating
View Scheme
Multi-step reaction with 3 steps
1: 1) Bu2SnO / 1) benzene, reflux, 24 h, 2) toluene, a) -40 deg C, 2 h, b) to r.t.
2: 64 percent / 4-(dimethylamino)pyridine, 4-(dimethylamino)pyridine hydrochloride, dicyclohexylcarbodiimide / CHCl3 / 85 h
3: 86 percent / Ph3C*BF4 / CH2Cl2 / 48 h / Heating
View Scheme
(2R,3R,4R)-2,3,4-Trimethyl-2,3-(methylenedioxy)pentanedioic acid
109494-78-2, 121787-04-0

(2R,3R,4R)-2,3,4-Trimethyl-2,3-(methylenedioxy)pentanedioic acid

monocrotaline
315-22-0

monocrotaline

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: Ac2O / CH2Cl2 / 3.5 h / Heating
2: 1) Bu2SnO / 1) benzene, reflux, 24 h, 2) toluene, a) -40 deg C, 2 h, b) to r.t.
3: 1) Et3N, 2,4,6-trichlorobenzoyl chloride, 2) 4-(dimethylamino)pyridine / 1) THF, r.t., 3.5 h, 2) THF, toluene, reflux, 10 min
4: 86 percent / Ph3C*BF4 / CH2Cl2 / 48 h / Heating
View Scheme
Multi-step reaction with 4 steps
1: Ac2O / CH2Cl2 / 3.5 h / Heating
2: 1) Bu2SnO / 1) benzene, reflux, 24 h, 2) toluene, a) -40 deg C, 2 h, b) to r.t.
3: 64 percent / 4-(dimethylamino)pyridine, 4-(dimethylamino)pyridine hydrochloride, dicyclohexylcarbodiimide / CHCl3 / 85 h
4: 86 percent / Ph3C*BF4 / CH2Cl2 / 48 h / Heating
View Scheme
(2'R,3R,4S)-5-<2'-methoxy-2'-(trifluoromethyl)phenylacetoxy>-2,3,4-trimethyl-3,4-methylenedioxy-2-pentene
121719-94-6

(2'R,3R,4S)-5-<2'-methoxy-2'-(trifluoromethyl)phenylacetoxy>-2,3,4-trimethyl-3,4-methylenedioxy-2-pentene

monocrotaline
315-22-0

monocrotaline

Conditions
ConditionsYield
Multi-step reaction with 8 steps
1: 1) BH3*THF, 2) 3 M NaOH, 30percent H2O2 / 1) THF, 0 deg C, 20 h, 2) THF, r.t., 3 h
2: 1) (COCl)2, DMSO, 2) Et3N / 1) CH2Cl2, -78 deg C, 2 min, 2) CH2Cl2, -78 deg C, 1 h
3: 1 M KMnO4 / 2-methyl-propan-2-ol / 0.08 h / pH 7 phosphate buffer
4: 86 percent / 1 M NaOH, Na2RuO4 / 0.5 h / Ambient temperature
5: Ac2O / CH2Cl2 / 3.5 h / Heating
6: 1) Bu2SnO / 1) benzene, reflux, 24 h, 2) toluene, a) -40 deg C, 2 h, b) to r.t.
7: 1) Et3N, 2,4,6-trichlorobenzoyl chloride, 2) 4-(dimethylamino)pyridine / 1) THF, r.t., 3.5 h, 2) THF, toluene, reflux, 10 min
8: 86 percent / Ph3C*BF4 / CH2Cl2 / 48 h / Heating
View Scheme
Multi-step reaction with 8 steps
1: 1) BH3*THF, 2) 3 M NaOH, 30percent H2O2 / 1) THF, 0 deg C, 20 h, 2) THF, r.t., 3 h
2: 1) (COCl)2, DMSO, 2) Et3N / 1) CH2Cl2, -78 deg C, 2 min, 2) CH2Cl2, -78 deg C, 1 h
3: 1 M KMnO4 / 2-methyl-propan-2-ol / 0.08 h / pH 7 phosphate buffer
4: 86 percent / 1 M NaOH, Na2RuO4 / 0.5 h / Ambient temperature
5: Ac2O / CH2Cl2 / 3.5 h / Heating
6: 1) Bu2SnO / 1) benzene, reflux, 24 h, 2) toluene, a) -40 deg C, 2 h, b) to r.t.
7: 64 percent / 4-(dimethylamino)pyridine, 4-(dimethylamino)pyridine hydrochloride, dicyclohexylcarbodiimide / CHCl3 / 85 h
8: 86 percent / Ph3C*BF4 / CH2Cl2 / 48 h / Heating
View Scheme
(R)-3,3,3-Trifluoro-2-methoxy-2-phenyl-propionic acid (4S,5R)-4,5-dimethyl-5-((R)-1-methyl-2-oxo-ethyl)-[1,3]dioxolan-4-ylmethyl ester
146070-68-0

(R)-3,3,3-Trifluoro-2-methoxy-2-phenyl-propionic acid (4S,5R)-4,5-dimethyl-5-((R)-1-methyl-2-oxo-ethyl)-[1,3]dioxolan-4-ylmethyl ester

monocrotaline
315-22-0

monocrotaline

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: 1 M KMnO4 / 2-methyl-propan-2-ol / 0.08 h / pH 7 phosphate buffer
2: 86 percent / 1 M NaOH, Na2RuO4 / 0.5 h / Ambient temperature
3: Ac2O / CH2Cl2 / 3.5 h / Heating
4: 1) Bu2SnO / 1) benzene, reflux, 24 h, 2) toluene, a) -40 deg C, 2 h, b) to r.t.
5: 1) Et3N, 2,4,6-trichlorobenzoyl chloride, 2) 4-(dimethylamino)pyridine / 1) THF, r.t., 3.5 h, 2) THF, toluene, reflux, 10 min
6: 86 percent / Ph3C*BF4 / CH2Cl2 / 48 h / Heating
View Scheme
Multi-step reaction with 6 steps
1: 1 M KMnO4 / 2-methyl-propan-2-ol / 0.08 h / pH 7 phosphate buffer
2: 86 percent / 1 M NaOH, Na2RuO4 / 0.5 h / Ambient temperature
3: Ac2O / CH2Cl2 / 3.5 h / Heating
4: 1) Bu2SnO / 1) benzene, reflux, 24 h, 2) toluene, a) -40 deg C, 2 h, b) to r.t.
5: 64 percent / 4-(dimethylamino)pyridine, 4-(dimethylamino)pyridine hydrochloride, dicyclohexylcarbodiimide / CHCl3 / 85 h
6: 86 percent / Ph3C*BF4 / CH2Cl2 / 48 h / Heating
View Scheme
(2'R,2S,3R,4S)-5-<2'-methoxy-2'-(trifluoromethyl)phenylacetoxy>-2,3,4-trimethyl-3,4-methylenedioxypentanoic acid
121719-96-8

(2'R,2S,3R,4S)-5-<2'-methoxy-2'-(trifluoromethyl)phenylacetoxy>-2,3,4-trimethyl-3,4-methylenedioxypentanoic acid

monocrotaline
315-22-0

monocrotaline

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 86 percent / 1 M NaOH, Na2RuO4 / 0.5 h / Ambient temperature
2: Ac2O / CH2Cl2 / 3.5 h / Heating
3: 1) Bu2SnO / 1) benzene, reflux, 24 h, 2) toluene, a) -40 deg C, 2 h, b) to r.t.
4: 1) Et3N, 2,4,6-trichlorobenzoyl chloride, 2) 4-(dimethylamino)pyridine / 1) THF, r.t., 3.5 h, 2) THF, toluene, reflux, 10 min
5: 86 percent / Ph3C*BF4 / CH2Cl2 / 48 h / Heating
View Scheme
Multi-step reaction with 5 steps
1: 86 percent / 1 M NaOH, Na2RuO4 / 0.5 h / Ambient temperature
2: Ac2O / CH2Cl2 / 3.5 h / Heating
3: 1) Bu2SnO / 1) benzene, reflux, 24 h, 2) toluene, a) -40 deg C, 2 h, b) to r.t.
4: 64 percent / 4-(dimethylamino)pyridine, 4-(dimethylamino)pyridine hydrochloride, dicyclohexylcarbodiimide / CHCl3 / 85 h
5: 86 percent / Ph3C*BF4 / CH2Cl2 / 48 h / Heating
View Scheme
(2'R,3R,4S)-5-<2'-methoxy-2'-(trifluoromethyl)phenylacetoxy>-2,3,4-trimethyl-3,4-methylenedioxy-2-pentanol
121719-93-5, 121787-08-4

(2'R,3R,4S)-5-<2'-methoxy-2'-(trifluoromethyl)phenylacetoxy>-2,3,4-trimethyl-3,4-methylenedioxy-2-pentanol

monocrotaline
315-22-0

monocrotaline

Conditions
ConditionsYield
Multi-step reaction with 9 steps
1: 83 percent / POCl3, pyridine / 17 h / 85 °C
2: 1) BH3*THF, 2) 3 M NaOH, 30percent H2O2 / 1) THF, 0 deg C, 20 h, 2) THF, r.t., 3 h
3: 1) (COCl)2, DMSO, 2) Et3N / 1) CH2Cl2, -78 deg C, 2 min, 2) CH2Cl2, -78 deg C, 1 h
4: 1 M KMnO4 / 2-methyl-propan-2-ol / 0.08 h / pH 7 phosphate buffer
5: 86 percent / 1 M NaOH, Na2RuO4 / 0.5 h / Ambient temperature
6: Ac2O / CH2Cl2 / 3.5 h / Heating
7: 1) Bu2SnO / 1) benzene, reflux, 24 h, 2) toluene, a) -40 deg C, 2 h, b) to r.t.
8: 1) Et3N, 2,4,6-trichlorobenzoyl chloride, 2) 4-(dimethylamino)pyridine / 1) THF, r.t., 3.5 h, 2) THF, toluene, reflux, 10 min
9: 86 percent / Ph3C*BF4 / CH2Cl2 / 48 h / Heating
View Scheme
Multi-step reaction with 9 steps
1: 83 percent / POCl3, pyridine / 17 h / 85 °C
2: 1) BH3*THF, 2) 3 M NaOH, 30percent H2O2 / 1) THF, 0 deg C, 20 h, 2) THF, r.t., 3 h
3: 1) (COCl)2, DMSO, 2) Et3N / 1) CH2Cl2, -78 deg C, 2 min, 2) CH2Cl2, -78 deg C, 1 h
4: 1 M KMnO4 / 2-methyl-propan-2-ol / 0.08 h / pH 7 phosphate buffer
5: 86 percent / 1 M NaOH, Na2RuO4 / 0.5 h / Ambient temperature
6: Ac2O / CH2Cl2 / 3.5 h / Heating
7: 1) Bu2SnO / 1) benzene, reflux, 24 h, 2) toluene, a) -40 deg C, 2 h, b) to r.t.
8: 64 percent / 4-(dimethylamino)pyridine, 4-(dimethylamino)pyridine hydrochloride, dicyclohexylcarbodiimide / CHCl3 / 85 h
9: 86 percent / Ph3C*BF4 / CH2Cl2 / 48 h / Heating
View Scheme
(2'R,2S,3R,4S)-5-<2'-methoxy-2'-(trifluoromethyl)phenylacetoxy>-2,3,4-trimethyl-3,4-methylenedioxy-1-pentanol
121719-95-7, 121787-09-5

(2'R,2S,3R,4S)-5-<2'-methoxy-2'-(trifluoromethyl)phenylacetoxy>-2,3,4-trimethyl-3,4-methylenedioxy-1-pentanol

monocrotaline
315-22-0

monocrotaline

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1: 1) (COCl)2, DMSO, 2) Et3N / 1) CH2Cl2, -78 deg C, 2 min, 2) CH2Cl2, -78 deg C, 1 h
2: 1 M KMnO4 / 2-methyl-propan-2-ol / 0.08 h / pH 7 phosphate buffer
3: 86 percent / 1 M NaOH, Na2RuO4 / 0.5 h / Ambient temperature
4: Ac2O / CH2Cl2 / 3.5 h / Heating
5: 1) Bu2SnO / 1) benzene, reflux, 24 h, 2) toluene, a) -40 deg C, 2 h, b) to r.t.
6: 1) Et3N, 2,4,6-trichlorobenzoyl chloride, 2) 4-(dimethylamino)pyridine / 1) THF, r.t., 3.5 h, 2) THF, toluene, reflux, 10 min
7: 86 percent / Ph3C*BF4 / CH2Cl2 / 48 h / Heating
View Scheme
Multi-step reaction with 7 steps
1: 1) (COCl)2, DMSO, 2) Et3N / 1) CH2Cl2, -78 deg C, 2 min, 2) CH2Cl2, -78 deg C, 1 h
2: 1 M KMnO4 / 2-methyl-propan-2-ol / 0.08 h / pH 7 phosphate buffer
3: 86 percent / 1 M NaOH, Na2RuO4 / 0.5 h / Ambient temperature
4: Ac2O / CH2Cl2 / 3.5 h / Heating
5: 1) Bu2SnO / 1) benzene, reflux, 24 h, 2) toluene, a) -40 deg C, 2 h, b) to r.t.
6: 64 percent / 4-(dimethylamino)pyridine, 4-(dimethylamino)pyridine hydrochloride, dicyclohexylcarbodiimide / CHCl3 / 85 h
7: 86 percent / Ph3C*BF4 / CH2Cl2 / 48 h / Heating
View Scheme
(4R,5R)-5-((R)-1-Carboxy-ethyl)-4,5-dimethyl-[1,3]dioxolane-4-carboxylic acid (7R,7aR)-7-hydroxy-5,6,7,7a-tetrahydro-3H-pyrrolizin-1-ylmethyl ester
121719-97-9

(4R,5R)-5-((R)-1-Carboxy-ethyl)-4,5-dimethyl-[1,3]dioxolane-4-carboxylic acid (7R,7aR)-7-hydroxy-5,6,7,7a-tetrahydro-3H-pyrrolizin-1-ylmethyl ester

monocrotaline
315-22-0

monocrotaline

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 1) Et3N, 2,4,6-trichlorobenzoyl chloride, 2) 4-(dimethylamino)pyridine / 1) THF, r.t., 3.5 h, 2) THF, toluene, reflux, 10 min
2: 86 percent / Ph3C*BF4 / CH2Cl2 / 48 h / Heating
View Scheme
Multi-step reaction with 2 steps
1: 64 percent / 4-(dimethylamino)pyridine, 4-(dimethylamino)pyridine hydrochloride, dicyclohexylcarbodiimide / CHCl3 / 85 h
2: 86 percent / Ph3C*BF4 / CH2Cl2 / 48 h / Heating
View Scheme
(4R,5S)-5-[(R)-2-(Diethoxy-phosphoryloxy)-1-methyl-2-oxo-ethyl]-4,5-dimethyl-[1,3]dioxolane-4-carboxylic acid 2-trimethylsilanyl-ethyl ester

(4R,5S)-5-[(R)-2-(Diethoxy-phosphoryloxy)-1-methyl-2-oxo-ethyl]-4,5-dimethyl-[1,3]dioxolane-4-carboxylic acid 2-trimethylsilanyl-ethyl ester

monocrotaline
315-22-0

monocrotaline

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: tetrahydrofuran / Ambient temperature
2: 96 percent / 5percent aqueous HF / tetrahydrofuran
3: Et3N / CH2Cl2
4: 71 percent / Bu4N(1+)F(1-)*3H2O / acetonitrile / 34 °C
5: 75 percent / 38percent HCl / ethane-1,2-diol / 2 h / 110 °C
View Scheme
(4R,5S)-5-[(R)-1-((1R,7aR)-7-Hydroxymethyl-2,3,5,7a-tetrahydro-1H-pyrrolizin-1-yloxycarbonyl)-ethyl]-4,5-dimethyl-[1,3]dioxolane-4-carboxylic acid 2-trimethylsilanyl-ethyl ester
109391-29-9

(4R,5S)-5-[(R)-1-((1R,7aR)-7-Hydroxymethyl-2,3,5,7a-tetrahydro-1H-pyrrolizin-1-yloxycarbonyl)-ethyl]-4,5-dimethyl-[1,3]dioxolane-4-carboxylic acid 2-trimethylsilanyl-ethyl ester

monocrotaline
315-22-0

monocrotaline

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: Et3N / CH2Cl2
2: 71 percent / Bu4N(1+)F(1-)*3H2O / acetonitrile / 34 °C
3: 75 percent / 38percent HCl / ethane-1,2-diol / 2 h / 110 °C
View Scheme
(4R,5S)-5-{(R)-1-[(1R,7aR)-7-(tert-Butyl-dimethyl-silanyloxymethyl)-2,3,5,7a-tetrahydro-1H-pyrrolizin-1-yloxycarbonyl]-ethyl}-4,5-dimethyl-[1,3]dioxolane-4-carboxylic acid 2-trimethylsilanyl-ethyl ester
109432-25-9

(4R,5S)-5-{(R)-1-[(1R,7aR)-7-(tert-Butyl-dimethyl-silanyloxymethyl)-2,3,5,7a-tetrahydro-1H-pyrrolizin-1-yloxycarbonyl]-ethyl}-4,5-dimethyl-[1,3]dioxolane-4-carboxylic acid 2-trimethylsilanyl-ethyl ester

monocrotaline
315-22-0

monocrotaline

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 96 percent / 5percent aqueous HF / tetrahydrofuran
2: Et3N / CH2Cl2
3: 71 percent / Bu4N(1+)F(1-)*3H2O / acetonitrile / 34 °C
4: 75 percent / 38percent HCl / ethane-1,2-diol / 2 h / 110 °C
View Scheme
(4R,5S)-5-[(R)-1-((1R,7aR)-7-Methanesulfonyloxymethyl-2,3,5,7a-tetrahydro-1H-pyrrolizin-1-yloxycarbonyl)-ethyl]-4,5-dimethyl-[1,3]dioxolane-4-carboxylic acid 2-trimethylsilanyl-ethyl ester

(4R,5S)-5-[(R)-1-((1R,7aR)-7-Methanesulfonyloxymethyl-2,3,5,7a-tetrahydro-1H-pyrrolizin-1-yloxycarbonyl)-ethyl]-4,5-dimethyl-[1,3]dioxolane-4-carboxylic acid 2-trimethylsilanyl-ethyl ester

monocrotaline
315-22-0

monocrotaline

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 71 percent / Bu4N(1+)F(1-)*3H2O / acetonitrile / 34 °C
2: 75 percent / 38percent HCl / ethane-1,2-diol / 2 h / 110 °C
View Scheme
Lithium; (1R,7aR)-7-(tert-butyl-dimethyl-silanyloxymethyl)-2,3,5,7a-tetrahydro-1H-pyrrolizin-1-olate
89710-47-4

Lithium; (1R,7aR)-7-(tert-butyl-dimethyl-silanyloxymethyl)-2,3,5,7a-tetrahydro-1H-pyrrolizin-1-olate

monocrotaline
315-22-0

monocrotaline

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: tetrahydrofuran / Ambient temperature
2: 96 percent / 5percent aqueous HF / tetrahydrofuran
3: Et3N / CH2Cl2
4: 71 percent / Bu4N(1+)F(1-)*3H2O / acetonitrile / 34 °C
5: 75 percent / 38percent HCl / ethane-1,2-diol / 2 h / 110 °C
View Scheme
(4R,5R)-5-((R)-1-Carboxy-ethyl)-4,5-dimethyl-[1,3]dioxolane-4-carboxylic acid (7R,7aS)-7-hydroxy-5,6,7,7a-tetrahydro-3H-pyrrolizin-1-yl ester

(4R,5R)-5-((R)-1-Carboxy-ethyl)-4,5-dimethyl-[1,3]dioxolane-4-carboxylic acid (7R,7aS)-7-hydroxy-5,6,7,7a-tetrahydro-3H-pyrrolizin-1-yl ester

monocrotaline
315-22-0

monocrotaline

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 1.) 2,4,6-trichlorobenzoyl chloride, 2.) 4-dimethylaminopyridine / 1.) THF, room temperature, 3.5 h, 2.) toluene, reflux, 10 min
2: 1.) Ph3CBF4, 2.) 1M HCl / 1.) CH2Cl2, reflux, 48 h, 2.) room temperature, 17.5 h
View Scheme
monocrotaline
315-22-0

monocrotaline

retronecine
480-85-3

retronecine

Conditions
ConditionsYield
With methanol; potassium hydroxide at 100℃; for 0.0833333h; Microwave irradiation;99%
With barium dihydroxide In water 1.) from 40 deg C to 50 deg C, 2 h, 2.) reflux, 2 h;91%
With barium dihydroxide for 2h; heating;81%
monocrotaline
315-22-0

monocrotaline

retronecanol
567-39-5

retronecanol

Conditions
ConditionsYield
With platinum(IV) oxide; hydrogen In water; isopropyl alcohol at 80℃; under 750.075 Torr; Solvent; Pressure; Temperature; Flow reactor;61%
monocrotaline
315-22-0

monocrotaline

Monocrotalic acid
26543-09-9

Monocrotalic acid

Conditions
ConditionsYield
With ethanol; acetic acid; platinum Hydrogenation;
With ethanol; nickel Hydrogenation;
monocrotaline
315-22-0

monocrotaline

1,2-didehydro-7β-hydroxy-1-methyl-8α-pyrrolizidine
6029-72-7

1,2-didehydro-7β-hydroxy-1-methyl-8α-pyrrolizidine

Conditions
ConditionsYield
With quinoline; Pd/SrCO3; ethanol Hydrogenation;
monocrotaline
315-22-0

monocrotaline

Monocrotaline N-oxide
35337-98-5

Monocrotaline N-oxide

Conditions
ConditionsYield
With ethanol; dihydrogen peroxide
With dihydrogen peroxide
monocrotaline
315-22-0

monocrotaline

A

spectabiline
520-55-8

spectabiline

B

12,13-diacetoxy-(13βH,14βH)-14,19-dihydro-20-nor-crotalanane-11,15-dione
25490-68-0

12,13-diacetoxy-(13βH,14βH)-14,19-dihydro-20-nor-crotalanane-11,15-dione

Conditions
ConditionsYield
With acetyl chloride
monocrotaline
315-22-0

monocrotaline

12,13-[(Ξ)-sulfinyldioxy-(13βH,14βH)-14,19-dihydro-20-nor-crotalanan-11,15-dione
77057-77-3

12,13-[(Ξ)-sulfinyldioxy-(13βH,14βH)-14,19-dihydro-20-nor-crotalanan-11,15-dione

Conditions
ConditionsYield
With thionyl chloride
monocrotaline
315-22-0

monocrotaline

(7aR)-7t-methyl-(7ar)-hexahydro-pyrrolizin-1t-ol; salt with monocrotalic acid

(7aR)-7t-methyl-(7ar)-hexahydro-pyrrolizin-1t-ol; salt with monocrotalic acid

Conditions
ConditionsYield
With ethanol; acetic acid; platinum under 2206.5 Torr; Hydration;
With ethanol; nickel under 2206.5 Torr; Hydration;
monocrotaline
315-22-0

monocrotaline

A

2,3-dimethyl-4-oxo-valeric acid
526-79-4

2,3-dimethyl-4-oxo-valeric acid

B

retronecine
480-85-3

retronecine

Conditions
ConditionsYield
With barium dihydroxide; water
acetic anhydride
108-24-7

acetic anhydride

monocrotaline
315-22-0

monocrotaline

12,13-diacetoxy-(13βH,14βH)-14,19-dihydro-20-nor-crotalanane-11,15-dione
25490-68-0

12,13-diacetoxy-(13βH,14βH)-14,19-dihydro-20-nor-crotalanane-11,15-dione

Conditions
ConditionsYield
With acetyl chloride
monocrotaline
315-22-0

monocrotaline

2,3,4-trimethyl-L-2-deoxy-arabinitol

2,3,4-trimethyl-L-2-deoxy-arabinitol

Conditions
ConditionsYield
With lithium aluminium tetrahydride In tetrahydrofuran
monocrotaline
315-22-0

monocrotaline

(2R,3R,4R)-2,3,4-Trimethyl-2,3-(methylenedioxy)pentanedioic acid
109494-78-2, 121787-04-0

(2R,3R,4R)-2,3,4-Trimethyl-2,3-(methylenedioxy)pentanedioic acid

Conditions
ConditionsYield
Multistep reaction;
monocrotaline
315-22-0

monocrotaline

A

spectabiline
520-55-8

spectabiline

B

O,O'-diacetyl-monocrotaline

O,O'-diacetyl-monocrotaline

Conditions
ConditionsYield
With acetyl chloride
Ketene
463-51-4

Ketene

monocrotaline
315-22-0

monocrotaline

A

12,13-carbonyldioxy-(13βH,14βH)-14,19-dihydro-20-nor-crotalanan-11,15-dione
76971-16-9

12,13-carbonyldioxy-(13βH,14βH)-14,19-dihydro-20-nor-crotalanan-11,15-dione

B

spectabiline

spectabiline

Conditions
ConditionsYield
With chloroform
monocrotaline
315-22-0

monocrotaline

Dehydroretronecine
23107-12-2

Dehydroretronecine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 81 percent / Ba(OH)2*8H2O / 2 h / heating
2: 40 percent / o-bromanil / CHCl3 / 0.03 h
View Scheme
monocrotaline
315-22-0

monocrotaline

5'-monophosphate of 7-(deoxyguanosin-N2-yl)dehydrosupinidine
103958-13-0

5'-monophosphate of 7-(deoxyguanosin-N2-yl)dehydrosupinidine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 81 percent / Ba(OH)2*8H2O / 2 h / heating
2: 40 percent / o-bromanil / CHCl3 / 0.03 h
3: 0.9 percent / aq. K2CO3 / 6 h / 60 °C / pH 7.4
View Scheme
monocrotaline
315-22-0

monocrotaline

hydroquinone

hydroquinone

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 81 percent / Ba(OH)2*8H2O / 2 h / heating
2: o-bromanil / CHCl3 / 0.03 h
View Scheme
monocrotaline
315-22-0

monocrotaline

3'-monophosphate of 7-(deoxyadenosine-N6-yl)dehydrosupinidine

3'-monophosphate of 7-(deoxyadenosine-N6-yl)dehydrosupinidine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 81 percent / Ba(OH)2*8H2O / 2 h / heating
2: 40 percent / o-bromanil / CHCl3 / 0.03 h
3: aq. K2CO3 / 40 h / 60 °C / pH 8.0
View Scheme
monocrotaline
315-22-0

monocrotaline

3'-monophosphate of 7-(deoxyguanosin-N2-yl)dehydrosupinidine
612490-81-0

3'-monophosphate of 7-(deoxyguanosin-N2-yl)dehydrosupinidine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 81 percent / Ba(OH)2*8H2O / 2 h / heating
2: 40 percent / o-bromanil / CHCl3 / 0.03 h
3: 2.5 percent / aq. K2CO3 / 6 h / 60 °C / pH 8.0 / stirred anaerobically
View Scheme
monocrotaline
315-22-0

monocrotaline

3',5'-bisphosphate of 7-(deoxyguanosin-N2-yl)dehydrosupinidine

3',5'-bisphosphate of 7-(deoxyguanosin-N2-yl)dehydrosupinidine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 81 percent / Ba(OH)2*8H2O / 2 h / heating
2: 40 percent / o-bromanil / CHCl3 / 0.03 h
3: 2.5 percent / aq. K2CO3 / 6 h / 60 °C / pH 8.0 / stirred anaerobically
4: dithiotreitol; ATP; MgCl2 / cloned T4 polynucleotide kinase / H2O / 0.67 h / 37 °C / pH 9.5
View Scheme
monocrotaline
315-22-0

monocrotaline

platynecine
520-62-7

platynecine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: Ba(OH)2 / H2O / 1 h / Heating
2: 20 mg / hydrogen / Pd/C / ethanol / 2 h
View Scheme
Multi-step reaction with 2 steps
1: potassium hydroxide; methanol / 0.08 h / 100 °C / Microwave irradiation
2: hydrogen / ethanol / 50 °C / 750.08 Torr / Flow reactor
View Scheme
monocrotaline
315-22-0

monocrotaline

(7R,7aR)-7-Hydroxy-5,6,7,7a-tetrahydro-3H-pyrrolizine-1-carbaldehyde
154922-76-6

(7R,7aR)-7-Hydroxy-5,6,7,7a-tetrahydro-3H-pyrrolizine-1-carbaldehyde

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 91 percent / Ba(OH)2*8H2O / H2O / 1.) from 40 deg C to 50 deg C, 2 h, 2.) reflux, 2 h
2: Dess-Martin periodinane, CF3COOH / CH2Cl2 / 1 h
View Scheme
monocrotaline
315-22-0

monocrotaline

<9-2H>-retronecine

<9-2H>-retronecine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 91 percent / Ba(OH)2*8H2O / H2O / 1.) from 40 deg C to 50 deg C, 2 h, 2.) reflux, 2 h
2: Dess-Martin periodinane, CF3COOH / CH2Cl2 / 1 h
3: NaB(2)H4 / methanol / 0.5 h / 0 °C
View Scheme

Monocrotaline Consensus Reports

IARC Cancer Review: Group 2B IMEMDT    IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 7 ,1987,p. 56.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Animal Limited Evidence IMEMDT    IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 10 ,1976,p. 291.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) . EPA Genetic Toxicology Program.

Monocrotaline Specification

The systematic name of Monocrotaline is (3R,4R,5R,13aR,13bR)-4,5-dihydroxy-3,4,5-trimethyl-4,5,8,10,12,13,13a,13b-octahydro-2H-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione. With the CAS registry number 315-22-0, it is also named as (13-alpha,14-alpha)-14,19-Dihydro-12,13-dihydroxy-20-norcrotalanan-11,15-dione. The product's category is Miscellaneous Natural Products. Besides, it is white to light tan powder, which should be stored in sealed and dry place at 2-8 °C. This chemical is anticarcinoma drug that is used for biochemical research. In addition, its molecular formula is C16H23NO6 and molecular weight is 325.35692.

Physical properties about Monocrotaline are: (1)ACD/LogP: -4.137; (2)ACD/LogD (pH 5.5): -4.76; (3)ACD/LogD (pH 7.4): -4.15; (4)ACD/BCF (pH 5.5): 1.00; (5)ACD/BCF (pH 7.4): 1.00; (6)ACD/KOC (pH 5.5): 1.00; (7)ACD/KOC (pH 7.4): 1.00; (8)#H bond acceptors: 7; (9)#H bond donors: 2; (10)#Freely Rotating Bonds: 2; (11)Index of Refraction: 1.586; (12)Molar Refractivity: 80.3 cm3; (13)Molar Volume: 239.352 cm3; (14)Polarizability: 31.834 10-24cm3; (15)Surface Tension: 59.2760009765625 dyne/cm; (16)Density: 1.359 g/cm3; (17)Flash Point: 278.731 °C; (18)Enthalpy of Vaporization: 93.63 kJ/mol; (19)Boiling Point: 537.27 °C at 760 mmHg

When you are using this chemical, please be cautious about it as the following: it is toxic if swallowed. Limited evidence of a carcinogenic effect. You should wear suitable protective clothing, gloves and eye/face protection. Moreover, in case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)

You can still convert the following datas into molecular structure:
(1)InChI=1S/C16H23NO6/c1-9-13(18)23-11-5-7-17-6-4-10(12(11)17)8-22-14(19)16(3,21)15(9,2)20/h4,9,11-12,20-21H,5-8H2,1-3H3/t9-,11+,12+,15+,16-/m0/s1;
(2)InChIKey=QVCMHGGNRFRMAD-XFGHUUIASA-N;
(3)Smiles[C@@H]12[C@H]3CCN1CC=C2COC(=O)[C@]([C@]([C@H](C(=O)O3)C)(C)O)(C)O

The toxicity data is as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mammal (species unspecified) LDLo unreported 60mg/kg (60mg/kg)   Pharmacological Reviews. Vol. 22, Pg. 429, 1970.
mouse LD50 intraperitoneal 259mg/kg (259mg/kg)   Toxicology and Applied Pharmacology. Vol. 59, Pg. 424, 1981.
mouse LD50 intravenous 261mg/kg (261mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 75, Pg. 78, 1942.
rat LD50 intravenous 92mg/kg (92mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 83, Pg. 265, 1945.
rat LD50 oral 66mg/kg (66mg/kg) LIVER: "HEPATITIS (HEPATOCELLULAR NECROSIS), DIFFUSE" Toxicology and Applied Pharmacology. Vol. 18, Pg. 387, 1971.
rat LD50 subcutaneous 60mg/kg (60mg/kg)   Toxicology and Applied Pharmacology. Vol. 23, Pg. 470, 1972.
rat LD50 unreported 60mg/kg (60mg/kg)   Cancer Research. Vol. 28, Pg. 2237, 1968.
rat LDLo intraperitoneal 130mg/kg (130mg/kg) LIVER: OTHER CHANGES

LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES
Chemico-Biological Interactions. Vol. 12, Pg. 299, 1976.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View